Retinal Lymphoma

1 clinical trials · Condition

Record	Firm	Date
Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular Lymphoma (NCT01722305)	Mayo Clinic	2013-04-08

Every clearance here is in the API, with alerts when new ones post.